Evidence map›Paper›PMID 36920366›Full record

ArticleACS synthetic biology2023

Standard Intein Gene Expression Ramps (SIGER) for Protein-Independent Expression Control.

Maxime Fages-Lartaud, Yasmin Mueller, Florence Elie, Gaston Courtade, Martin Frank Hohmann-Marriott

Open access · hybridAbstract read
In one paragraph

Article in ACS synthetic biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Deep learning-drivenSynthetic and systems biotechnology · 2027
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maxime Fages-LartaudDepartment of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim N-7491, Norway.ORCID 0000-0001-7105-5007
Yasmin MuellerDepartment of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim N-7491, Norway.
Florence ElieDepartment of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim N-7491, Norway.
Gaston CourtadeDepartment of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim N-7491, Norway.ORCID 0000-0002-1644-3223
Martin Frank Hohmann-MarriottDepartment of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim N-7491, Norway.
Norwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coordination of multigene expression is one of the key challenges of metabolic engineering for the development of cell factories. Constraints on translation initiation and early ribosome kinetics of mRNA are imposed by features of the 5'UTR in combination with the start of the gene, referred to as the "gene ramp", such as rare codons and mRNA secondary structures. These features strongly influence the translation yield and protein quality by regulating the ribosome distribution on mRNA strands. The utilization of genetic expression sequences, such as promoters and 5'UTRs in combination with different target genes, leads to a wide variety of gene ramp compositions with irregular translation rates, leading to unpredictable levels of protein yield and quality. Here, we present the Standard Intein Gene Expression Ramp (SIGER) system for controlling protein expression. The SIGER system makes use of inteins to decouple the translation initiation features from the gene of a target protein. We generated sequence-specific gene expression sequences for two inteins (DnaB and DnaX) that display defined levels of protein expression. Additionally, we used inteins that possess the ability to release the C-terminal fusion protein

Indexed as

InteinsProtein SplicingGene ExpressionProtein Processing, Post-TranslationalProteinsRNA, MessengerProteinsRNA, Messenger

Identifiers

PMID36920366
PMCPMC10127266
OpenAlexW4324311223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.